Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Revenue

Extrawell Pharmaceutical Holdings had revenue of 30.79M HKD in the half year ending September 30, 2024, a decrease of -9.69%. This brings the company's revenue in the last twelve months to 59.75M, down -12.93% year-over-year. In the fiscal year ending March 31, 2024, Extrawell Pharmaceutical Holdings had annual revenue of 59.10M, down -18.57%.

• Revenue (ttm): 59.75M
• Revenue Growth: -12.93%
• P/S Ratio: 2.04
• Revenue / Employee: 368.82K
• Employees: 159
• Market Cap: 121.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	59.10M	-13.48M	-18.57%
Mar 31, 2023	72.58M	-1.35M	-1.82%
Mar 31, 2022	73.93M	-4.88M	-6.19%
Mar 31, 2021	78.80M	1.22M	1.57%
Mar 31, 2020	77.58M	-11.63M	-13.04%